Potential mechanisms underlying the renoprotective effect of empagliflozin, a novel selective sodium glucose co-transporter (SGLT) 2 inhibitor, against diabetic nephropathy in st - Egyptian Knowledge Bank

141124

Potential mechanisms underlying the renoprotective effect of empagliflozin, a novel selective sodium glucose co-transporter (SGLT) 2 inhibitor, against diabetic nephropathy in st

Article

Last updated: 24 Dec 2024

Overview Similar Items

Article

The Potential Ameliorative Effect of Empagliflozin on Myocardium in Cardiorenal Syndrome 3 via Targeting Mitophagy and Mitochondrial Biogenesis in Adult Male Albino Rat Model: Bi

Article

Reno Protective Effect of Sodium Glucose Cotransporter-2 Inhibitor (Dapagliflozin) in Type 2 Diabetic Patients

Article

The Reno-protective effect of SGLT-2 inhibitors in non-diabetic patients. A comparative review

Article

The Effect of SGLT2 Inhibitors on the Development of Contrast-Induced Nephropathy in Diabetic Patients with Non-ST Segment Elevation Myocardial Infarction

Article

Pathophysiological Mechanisms of Diabetic Nephropathy: Role of S1R/Nrf2 Antioxidant Axis

Article

Effect of Sodium Glucose Co-transporter Type 2 Inhibitors on The Infract size among Diabetic Patients With ST Segment Elevation Myocardial Infarction Undergoing Primary Percutane

Article

The Efficacy of Canagliflozin on Type 2 Diabetic Nephropathy in Male Rats

Article

Role of Kidney Injury Molecule-1 Expression, Wnt Proteins (Beta- catenin) and Endogenous Irisin in a Rat Model of Renal fibrosis: Renoprotective Effect of Metformin

Article

Protective Effect of Sodium-Glucose Co-Transporter 2 Inhibitor (Dapagliflozin) on Diabetic Retinopathy in Streptozotocin Induced Diabetes in Rats

Article

Evaluation of Renoprotective Effect of Evolocumab and/or Telmisartan on Obesity-Induced Renal Injury in C57BL/6J Mice